Biotechnology company Moderna (NASDAQ:MRNA) reported in Q3 CY2025, but sales fell by 45.4% year on year to $1.02 billion. On ...

BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that ...

Moderna Inc became the second U.S company to release data from a large study of its experimental vaccine, saying it was 94.5% effective against COVID-19.

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

As BioNTech works to establish a production footprint for mRNA vaccines in Africa, two EU groups have offered financial backing to the company's efforts. The European Commission pledged a 35 million ...

Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology. He's seen here at a Sept. 4, 2025, hearing before the Senate Finance ...

A little less than a year after targeting Moderna in an mRNA vaccine patent lawsuit, GSK is widening the scope of its litigation by throwing its rival’s next-generation COVID-19 shot into the fold. In ...

Deborah Fuller receives funding from the National Institutes of Health. She is co-founder and a scientific advisor for two biotech companies developing nucleic acid vaccine technologies that are not ...

The United States recently took a dangerous step backward in its pursuit of lifesaving cures and pandemic preparedness. The Department of Health and Human Services shut down 22 federally funded mRNA ...

This month, the US Department of Health and Human Services announced that it was canceling 22 contracts and investments worth nearly $500 million as a part of a “coordinated wind-down” of mRNA vaccine ...

After the Department of Health and Human Services canceled about $500 million in funding for mRNA vaccine development, one senior agency leader has decided to call it quits. Alastair Thomson is ...

Former U.S. Surgeon General Jerome Adams pushed back against the Department of Health and Human Services (HHS) on Sunday for recently winding down its mRNA vaccine development activities via the ...